Clinical trials
Coronary Artery Disease trials in Belgium with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Active, not recruiting | 9 |
| Unknown status | 9 |
| Recruiting | 4 |
| Terminated | 4 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 8 |
| Elixir Medical Corporation | 7 |
| Biotronik AG | 4 |
| Hasselt University | 4 |
| Boston Scientific Corporation | 3 |
| Jessa Hospital | 3 |
| Medtronic Vascular | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Université Libre de Bruxelles | 2 |
| Aarhus University Hospital Skejby | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 75 |
| Myocardial Ischemia | 10 |
| Coronary Stenosis | 9 |
| Coronary Disease | 5 |
| Acute Coronary Syndrome | 4 |
| Angina Pectoris | 4 |
| Atherosclerosis | 4 |
| Cardiovascular Diseases | 4 |
| Coronary Restenosis | 4 |
| Angina, Stable | 3 |
Trials
Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.